 |
 |
 |
 |
 |
 |
 |
|
Brod M, Hammer M, Kragh N, Lessard S, Bushnell DM. Development and Validation of the Treatment Related Impact Measure of Weight (TRIM-Weight). Health Qual Life Outcomes. 2010. In press. Brod M, Christensen T, Kongsø JH, Bushnell DM. Examining and interpreting responsiveness of the Diabetes Medication Satisfaction measure. J Med Econ. 2009;12(4):309-16. Brod M, Tesler LE, Christensen TL. Qualitative research and content validity: developing best practices based on science and experience. Qual Life Res. 2009 Sep 27. [Epub ahead of print] Brod M, Hammer M, Christensen T, Lessard S, Bushnell DM. Understanding and assessing the impact of treatment in diabetes: the Treatment-Related Impact Measures for Diabetes and Devices (TRIM-Diabetes and TRIM-Diabetes Device).Health Qual Life Outcomes. 2009 Sep 9;7:83. Brod M, Verhaak CM, Weibinga CJ, Gerris J, Hoomans E. Improving clinical understanding of the effect of ovarian stimulation on women’s lives. Reprod Biomed Online. 2009;18(3):391–400. Brod M, Kongsø JH, Lessard S, Christensen TL. Psychological insulin resistance: patient beliefs and implications for diabetes management. Qual Life Res. 2009 Feb;18(1):23-32. Epub 2008 Nov 28. Brod M, Rousculp M, Cameron A. Understanding compliance issues for daily self-injectable treatment in ambulatory care settings. Patient Preference and Adherence. 2008;2:1-8. Matza LS, Johnston JA, Faries DE, Malley KG, Brod M. Responsiveness of the Adult Attention-Deficit/Hyperactivity Disorder Quality of Life Scale (AAQoL). Qual Life Res. 2007 Nov;16(9):1511-20. Brod M, Christensen T, Bushnell D. Maximizing the value of validation findings to better understand treatment satisfaction issues for diabetes. Qual Life Res. 2007 Aug;16(6):1053-63. Brod M, Cobden D, Lammert M, Bushnell D, Raskin P. Examining correlates of treatment satisfaction for injectable insulin in type 2 diabetes: lessons learned from a clinical trial comparing biphasic and basal analogues. Health Qual Life Outcomes. 2007 Feb 7;5:8. Brod M, Skovlund SE, Wittrup-Jensen KU. Measuring the impact of diabetes through patient report of treatment satisfaction, productivity and symptom experience. Qual Life Res. 2006 Apr;15(3):481-91. Brod M, Johnston J, Able S, Swindle R. Validation of the adult attention-deficit/hyperactivity disorder quality-of-life Scale (AAQoL): a disease-specific quality-of-life measure. Qual Life Res. 2006 Feb;15(1):117-29. Brod M, Perwein A, Adler L, Spencer T, Johnston J. Conceptualization and Assessment of Quality of Life for Adults with Attention-Deficit/Hyperactivity Disorder. Prim psychiatry. 2005;12(6):58-64. Colman SS, Brod M, Potter LP, Buesching DP, Rowland CR. Cross-sectional 7-year follow-up of anxiety in primary care patients. Depress Anxiety. 2004;19(2):105-11. Atkinson MJ, Sinha A, Hass SL, Colman SS, Kumar RN, Brod M, Rowland CR. Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease. Health Qual Life Outcomes. 2004 Feb 26;2:12. Sands LP, Ferreira P, Stewart AL, Brod M, Yaffe K. What explains differences between dementia patients' and their caregivers' ratings of patients' quality of life? Am J Geriatr Psychiatry. 2004 May-Jun;12(3):272-80. Anderson RT, Skovlund SE, Marrero D, Levine DW, Meadows K, Brod M, Balkrishnan R. Development and validation of the insulin treatment satisfaction questionnaire. Clin Ther. 2004 Apr;26(4):565-78. |